Pfizer to present infectious disease data at IDWeek 2026

Go back to Pfizer to present infectious disease data at IDWeek 2026

Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026

October 14, 2026 6:45 AM EDT

Data from 57 abstracts will highlight Pfizers scientific progress targeting infectious diseases, including pneumococcal disease and RSV

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) will present data from more than 50 company-sponsored, investigator-sponsored and collaborative research abstracts across its infectious disease pipeline and portfolio at the upcoming IDWeek 2026 congress, held in Washington, D.C., from... More